Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
DAP12 signaling | Homo sapiens |
Downstream TCR signaling | Homo sapiens |
Downstream signal transduction | Homo sapiens |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | Homo sapiens |
GPVI-mediated activation cascade | Homo sapiens |
IRS-mediated signalling | Homo sapiens |
Interleukin receptor SHC signaling | Homo sapiens |
Interleukin-3, Interleukin-5 and GM-CSF signaling | Homo sapiens |
Nephrin family interactions | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110758 | type 1 diabetes mellitus 21 | |
DOID:0110759 | type 1 diabetes mellitus 22 | |
DOID:0110760 | type 1 diabetes mellitus 23 | |
DOID:0110761 | type 1 diabetes mellitus 24 | |
DOID:0110858 | polycystic kidney disease 1 | |
DOID:0110892 | inflammatory bowel disease 1 | |
DOID:0110910 | leukocyte adhesion deficiency 1 | |
DOID:0111005 | cone-rod dystrophy 2 | |
DOID:0111029 | hemochromatosis type 1 | |
DOID:0111135 | congenital generalized lipodystrophy type 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024